- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04688762
The E-consult Application for Patients With Breast Cancer: Interest in Empathy and Empowerment of Patients. (e-CONSULT)
December 20, 2022 updated by: Centre Francois Baclesse
Demonstrate that the use of this application in consultation could improve the empathy perceived of the doctors by the patients after the consultation.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Observational
Enrollment (Actual)
206
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Caen, France
- Centre François Baclesse
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
14 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
Female
Sampling Method
Non-Probability Sample
Study Population
Patient with breast cancer with surgery indication
Description
Inclusion Criteria:
- Patient > 18 years old
- Patient referred for first consultation for surgery
- Patient referred for a breast tumorectomy and axillary sentinel node
- No patient opposition to participating in this study
Exclusion Criteria:
- Non-surgical management
- Management by any surgery other than breast tumorectomy and axillary sentinel node
- Any associated medical, social or psychopathological condition that could compromise the patient's ability to participate in the study
- Patient deprived of liberty or under guardianship
- Person subject to legal protection or unable to express their consent
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Observational Models: Cohort
- Time Perspectives: Prospective
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
Group without the e-consult tool
standard consultation
|
|
|
Group with the e-consult tool
The e-consult tool is a digital application developed and designed by the Center François Baclesse, This tool is a consultation support to explain the surgical management of the patient.
|
A numeric application used as a support in consultation to explain the surgical management of the patient.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Demonstrate that the use of this application in consultation could improve the empathy perceived of the doctors by the patients after the consultation.
Time Frame: before surgery
|
The average obtained in the CARE questionnaire by patients (score [10-50])
|
before surgery
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
December 24, 2020
Primary Completion (Actual)
November 16, 2022
Study Completion (Actual)
November 16, 2022
Study Registration Dates
First Submitted
December 24, 2020
First Submitted That Met QC Criteria
December 24, 2020
First Posted (Actual)
December 30, 2020
Study Record Updates
Last Update Posted (Actual)
December 21, 2022
Last Update Submitted That Met QC Criteria
December 20, 2022
Last Verified
December 1, 2022
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2020-A02045-34
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
No
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Breast Cancer
-
Baylor Breast Care CenterRecruitingBreast Cancer | Breast Neoplasm | Triple Negative Breast Cancer | Triple Negative Breast Neoplasms | HER2-positive Breast Cancer | Breast Cancer Stage II | Breast Cancer Female | Breast Cancer Stage III | Estrogen Receptor-positive Breast Cancer | Hormone Receptor-positive Breast Cancer | Breast Cancer InvasiveUnited States
-
Innocrin PharmaceuticalCompletedBreast Cancer | Advanced Breast Cancer | Metastatic Breast Cancer | Triple Negative Breast Cancer | Male Breast Cancer | ER+ Breast Cancer | Cancer of the BreastUnited States
-
Northwestern UniversityEisai Inc.UnknownMale Breast Cancer | Stage II Breast Cancer | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Triple-negative Breast Cancer | Stage IA Breast Cancer | Stage IB Breast Cancer | Stage IIIC Breast Cancer | Estrogen Receptor-negative Breast Cancer | Progesterone Receptor-negative Breast Cancer | HER2-negative...United States
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI)CompletedInflammatory Breast Cancer | Male Breast Cancer | Stage IV Breast Cancer | Stage IIIB Breast Cancer | Estrogen Receptor-negative Breast Cancer | Estrogen Receptor-positive Breast Cancer | Progesterone Receptor-negative Breast Cancer | Progesterone Receptor-positive Breast CancerUnited States
-
University of Colorado, DenverCompletedStage IV Breast Cancer | Stage II Breast Cancer | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Stage IA Breast Cancer | Stage IB Breast Cancer | Stage IIIC Breast CancerUnited States
-
Rutgers, The State University of New JerseyNational Cancer Institute (NCI); Rutgers Cancer Institute of New JerseyActive, not recruitingStage IIIA Breast Cancer | Stage IIIB Breast Cancer | Triple-negative Breast Cancer | Stage IIA Breast Cancer | Stage IIB Breast Cancer | Stage IIIC Breast Cancer | Estrogen Receptor-negative Breast Cancer | Progesterone Receptor-negative Breast Cancer | HER2-negative Breast CancerUnited States
-
University of Southern CaliforniaNational Cancer Institute (NCI)TerminatedMale Breast Cancer | Stage IV Breast Cancer | Stage II Breast Cancer | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Stage IA Breast Cancer | Stage IB Breast Cancer | Stage IIIC Breast Cancer | Recurrent Breast CancerUnited States
-
National Cancer Institute (NCI)TerminatedMale Breast Cancer | Stage IV Breast Cancer | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Triple-negative Breast Cancer | Stage IIIC Breast Cancer | Recurrent Breast Cancer | Estrogen Receptor-negative Breast Cancer | Progesterone Receptor-negative Breast Cancer | HER2-negative Breast CancerCanada
-
Mayo ClinicMarker Therapeutics, Inc.CompletedHER2-positive Breast Cancer | Male Breast Cancer | Stage II Breast Cancer | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Stage IIIC Breast CancerUnited States
-
University of Central FloridaFlorida Department of HealthRecruitingBreast Cancer | Breast Cancer Female | Breast Cancer Diagnosis | Breast Cancer Survivors | Breast Cancer Detection | Breast Cancer AwarenessUnited States
Clinical Trials on e-consult application (tool)
-
Seattle Institute for Biomedical and Clinical ResearchMinneapolis Veterans Affairs Medical Center; VA Puget Sound Health Care System and other collaboratorsNot yet recruitingSmoking Cessation | Pneumonia | HIV | Proton Pump Inhibitor | Inhaled CorticosteroidUnited States
-
Seattle Institute for Biomedical and Clinical ResearchUniversity of Colorado, Denver; Yale University; VA Connecticut Healthcare System and other collaboratorsCompletedHIV/AIDS | COPDUnited States
-
Massachusetts General HospitalCompleted
-
University of California, San DiegoPatient-Centered Outcomes Research Institute; University of California, Los... and other collaboratorsEnrolling by invitationUrinary IncontinenceUnited States
-
University Hospital, Clermont-FerrandCompleted
-
Oregon Research Behavioral Intervention Strategies...National Institute on Minority Health and Health Disparities (NIMHD)CompletedEarly Life StressUnited States
-
Lawson Health Research InstituteCanadian Orthopaedic FoundationCompleted
-
Pennington Biomedical Research CenterNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)CompletedObesity | OverweightUnited States
-
Oregon Research Behavioral Intervention Strategies...Oregon Research InstituteCompletedFamily Relations | Sibling RelationsUnited States
-
Gazi UniversityCompletedPregnant Women | Mobile Applications | Adaptation | Postpartum PeriodTurkey